RGC-32 is a novel regulator of the T-lymphocyte cell cycle
- 1 June 2015
- journal article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 98 (3) , 328-337
Abstract
No abstract availableKeywords
Funding Information
- Veterans Administration Merit Awards (BX001458, IMMB-002-065)
- POSDRU (159/1.5/S/138776)
This publication has 34 references indexed in Scilit:
- Epigenetic modifications induced by RGC-32 in colon cancerExperimental and Molecular Pathology, 2010
- Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survivalOncogene, 2008
- Response Gene to Complement 32 Expression Is Induced by the Luteinizing Hormone (LH) Surge and Regulated by LH-Induced Mediators in the Rodent OvaryEndocrinology, 2008
- C5b-9-induced Endothelial Cell Proliferation and Migration Are Dependent on Akt Inactivation of Forkhead Transcription Factor FOXO1Journal of Biological Chemistry, 2006
- Distinct gene expression patterns of peripheral blood cells in hyper–IgE syndromeClinical and Experimental Immunology, 2005
- 11,12-Epoxyeicosatrienoic Acid-induced Inhibition of FOXO Factors Promotes Endothelial Proliferation by Down-Regulating p27Journal of Biological Chemistry, 2003
- Activated Akt promotes increased resting T cell size, CD28‐independent T cell growth, and development of autoimmunity and lymphomaEuropean Journal of Immunology, 2003
- IL-2 activation of a PI3K-dependent STAT3 serine phosphorylation pathway in primary human T cellsCellular Signalling, 2003
- Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-γ but not TH2 cytokinesNature Immunology, 2001
- Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signallingNature, 1994